• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑山的戈谢病——基因型/表型相关性:五例报告

Gaucher disease in Montenegro - genotype/phenotype correlations: Five cases report.

作者信息

Vujosevic Snezana, Medenica Sanja, Vujicic Vesko, Dapcevic Milena, Bakic Nikola, Yang Ruhua, Liu Jun, Mistry Pramod K

机构信息

Department of Endocrinology, Internal Medicine Clinic, Clinical Center of Montenegro, Faculty of Medicine, University of Montenegro, Podgorica 81000, Montenegro.

Hematology Department, Internal Medicine Clinic, Clinical Center of Montenegro, Faculty of Medicine, University of Montenegro, Podgorica 81000, Montenegro.

出版信息

World J Clin Cases. 2019 Jun 26;7(12):1475-1482. doi: 10.12998/wjcc.v7.i12.1475.

DOI:10.12998/wjcc.v7.i12.1475
PMID:31363476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6656677/
Abstract

BACKGROUND

The most common lysosomal storage disorder is Gaucher disease (GD). It is a deficiency of lysosomal glucocerebrosidase (GBA) due to biallelic mutations in the gene, characterized by the deposition of glucocerebroside in macrophage-monocyte system cells. The report targets clinical phenotypes of GD in order to correlate them with gene mutations, as well as to identify gene mutation in patients in Montenegro that are diagnosed with GD.

CASES SUMMARY

Five patients (4 male, 1 female) of type 1 GD (GD1) are reported. The age at diagnosis ranged from 7 to 40. Patients experienced delays of 1-12 years in diagnosis after the original onset of symptoms. The most common mode of presentation was a variable degree of splenomegaly and thrombocytopenia, while other symptoms included bone pain, hepatomegaly, abdominal pain and fatigue. Osteopenia was present in a majority of the patients: 4/5. All patients were found to have an asymptomatic Erlenmeyer flask deformity of the distal femur. On enzyme replacement therapy (ERT), the hematological and visceral parameters showed significant improvement, but no significant progression in bone mineral density was noticed. gene sequencing revealed homozygosity for the mutation in one patient. The genotypes of the other patients were N370S/55bp deletion, N370S/D409H (2 patients), and H255Q/N370S (1 patient).

CONCLUSION

The phenotypes of the GD1 encountered in Montenegro were severe but all responded well to ERT.

摘要

背景

最常见的溶酶体贮积症是戈谢病(GD)。它是由于该基因的双等位基因突变导致溶酶体葡萄糖脑苷脂酶(GBA)缺乏,其特征是葡萄糖脑苷脂在巨噬细胞 - 单核细胞系统细胞中沉积。本报告旨在研究GD的临床表型,以便将它们与基因突变相关联,同时鉴定黑山地区被诊断为GD的患者的基因突变情况。

病例总结

报告了5例1型戈谢病(GD1)患者(4例男性,1例女性)。诊断时的年龄在7至40岁之间。患者在最初出现症状后1 - 12年才得以诊断。最常见的表现形式是不同程度的脾肿大和血小板减少,其他症状包括骨痛、肝肿大、腹痛和疲劳。大多数患者(4/5)存在骨质减少。所有患者均被发现有股骨远端无症状的烧瓶样畸形。接受酶替代疗法(ERT)后,血液学和内脏参数显示出显著改善,但骨密度未发现明显进展。基因测序显示1例患者存在该突变的纯合性。其他患者的基因型分别为N370S/55bp缺失、N370S/D409H(2例患者)和H255Q/N370S(1例患者)。

结论

黑山地区遇到的GD1表型严重,但所有患者对ERT反应良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2755/6656677/8019fc9d0b02/WJCC-7-1475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2755/6656677/8019fc9d0b02/WJCC-7-1475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2755/6656677/8019fc9d0b02/WJCC-7-1475-g001.jpg

相似文献

1
Gaucher disease in Montenegro - genotype/phenotype correlations: Five cases report.黑山的戈谢病——基因型/表型相关性:五例报告
World J Clin Cases. 2019 Jun 26;7(12):1475-1482. doi: 10.12998/wjcc.v7.i12.1475.
2
Gaucher disease: Biochemical and molecular findings in 141 patients diagnosed in Greece.戈谢病:希腊141例确诊患者的生化及分子学研究结果
Mol Genet Metab Rep. 2020 Jun 7;24:100614. doi: 10.1016/j.ymgmr.2020.100614. eCollection 2020 Sep.
3
Gaucher disease in North Macedonia: Unexpected prevalence of the N370S GBA1 allele with attenuated disease expression.北马其顿的戈谢病:N370S GBA1等位基因意外的高流行率及疾病表达减弱
Mol Genet Metab Rep. 2022 Jul 8;32:100895. doi: 10.1016/j.ymgmr.2022.100895. eCollection 2022 Sep.
4
Genotypes and phenotypes in 20 Chinese patients with type 2 Gaucher disease.20例2型戈谢病中国患者的基因型和表型
Brain Dev. 2018 Nov;40(10):876-883. doi: 10.1016/j.braindev.2018.06.006. Epub 2018 Jun 19.
5
Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene.戈谢病患者的基因型/表型关系。葡萄糖脑苷脂酶基因突变。
Clin Chem Lab Med. 2020 Jun 25;58(12):2017-2024. doi: 10.1515/cclm-2020-0306.
6
Clinical-genetic characteristics and treatment outcomes of Turkish children with Gaucher disease type 1 and type 3: A sixteen year single-center experience.土耳其 1 型和 3 型戈谢病患儿的临床遗传学特征和治疗结局:十六年单中心经验。
Eur J Med Genet. 2021 Nov;64(11):104339. doi: 10.1016/j.ejmg.2021.104339. Epub 2021 Sep 6.
7
Impact on bone microarchitecture and failure load in a patient with type I Gaucher disease who switched from Imiglucerase to Eliglustat.一名从伊米苷酶转换为依利格鲁司他的I型戈谢病患者的骨微结构和破坏载荷受到的影响。
Mol Genet Metab Rep. 2020 May 30;24:100606. doi: 10.1016/j.ymgmr.2020.100606. eCollection 2020 Sep.
8
Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.埃及儿童戈谢病患者的酶替代疗法与骨骼变化
J Inherit Metab Dis. 2006 Feb;29(1):92-8. doi: 10.1007/s10545-006-0121-6.
9
Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.I型戈谢病N370S纯合子的表型异质性:对来自国际戈谢病研究组(ICGG)戈谢病登记处的798例患者的分析
J Inherit Metab Dis. 2008 Dec;31(6):738-44. doi: 10.1007/s10545-008-0868-z. Epub 2008 Nov 3.
10
Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma.以巨脾和肝戈谢瘤为表现的小儿戈谢病
Children (Basel). 2023 May 12;10(5):869. doi: 10.3390/children10050869.

引用本文的文献

1
Current opinion on pluripotent stem cell technology in Gaucher's disease: challenges and future prospects.高雪氏病中多能干细胞技术的当前观点:挑战与未来前景
Cytotechnology. 2025 Feb;77(1):26. doi: 10.1007/s10616-024-00687-2. Epub 2024 Dec 27.
2
Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan.在日本,开发并评估了一种用于伴有或不伴有神经症状的戈谢病的患者报告结局测量工具。
Orphanet J Rare Dis. 2024 Jan 5;19(1):11. doi: 10.1186/s13023-023-02996-9.
3
Screening for Gaucher Disease Using Dried Blood Spot Tests: A Japanese Multicenter, Cross-sectional Survey.

本文引用的文献

1
Clinical course and prognosis in patients with Gaucher disease and parkinsonism.戈谢病伴帕金森病患者的临床病程和预后。
Neurol Genet. 2016 Mar 4;2(2):e57. doi: 10.1212/NXG.0000000000000057. eCollection 2016 Apr.
2
Clinical manifestations and management of Gaucher disease.戈谢病的临床表现与治疗
Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):157-64. doi: 10.11138/ccmbm/2015.12.2.157. Epub 2015 Oct 26.
3
Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.
应用干血斑检测法筛查戈谢病:一项日本多中心、横断面调查。
Intern Med. 2021;60(5):699-707. doi: 10.2169/internalmedicine.5064-20. Epub 2021 Mar 1.
戈谢病诱导的多能干细胞表现出红系分化潜能降低和异常髓系造血。
Stem Cells Transl Med. 2015 Aug;4(8):878-86. doi: 10.5966/sctm.2014-0213. Epub 2015 Jun 10.
4
Gaucher's disease: report of 11 cases with review of literature.高雪氏病:11例报告并文献复习
Pan Afr Med J. 2015 Jan 7;20:18. doi: 10.11604/pamj.2015.20.18.4112. eCollection 2015.
5
Gaucher disease.戈谢病
J Clin Exp Hepatol. 2014 Mar;4(1):37-50. doi: 10.1016/j.jceh.2014.02.005. Epub 2014 Apr 21.
6
Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease.葡萄糖脑苷脂酶 2 基因缺失可挽救 1 型戈谢病。
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4934-9. doi: 10.1073/pnas.1400768111. Epub 2014 Mar 17.
7
Gaucher disease and other storage disorders.戈谢病和其他贮积症。
Hematology Am Soc Hematol Educ Program. 2012;2012:13-8. doi: 10.1182/asheducation-2012.1.13.
8
Gaucher disease: insights from a rare Mendelian disorder.戈谢病:一种罕见孟德尔疾病的见解
Discov Med. 2012 Oct;14(77):273-81.
9
Gaucher disease gene GBA functions in immune regulation.戈谢病基因 GBA 参与免疫调节。
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):10018-23. doi: 10.1073/pnas.1200941109. Epub 2012 Jun 4.
10
The role of saposin C in Gaucher disease.载脂蛋白 C 在戈谢病中的作用。
Mol Genet Metab. 2012 Jul;106(3):257-63. doi: 10.1016/j.ymgme.2012.04.024. Epub 2012 May 5.